Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors

The synthesis of amidinoaryloxy 9-benzyl-8-methyl-9 H-purine, 7,8-dihydropteridine-6(5 H)-one and 5,7-dihydropyrimido[4,5- b][1,4]oxazine-6-one inhibitors of Factor Xa is described. These compounds show nanomolar potency against FXa and maintain high selectivity over thrombin and trypsin. The synthe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 1998-08, Vol.8 (16), p.2235-2240
Hauptverfasser: Buckman, Brad O., Mohan, Raju, Koovakkat, Sunil, Liang, Amy, Lan Trinh, Morrissey, Michael M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The synthesis of amidinoaryloxy 9-benzyl-8-methyl-9 H-purine, 7,8-dihydropteridine-6(5 H)-one and 5,7-dihydropyrimido[4,5- b][1,4]oxazine-6-one inhibitors of Factor Xa is described. These compounds show nanomolar potency against FXa and maintain high selectivity over thrombin and trypsin. The synthesis of amidinoaryloxy 9-benzyl-8-methyl-9 H-purine, 7,8-dihydro-pteridine-6(5 H)-one, and 5,7-dihydropyrimido[4,5- b][1,4]oxazine-6-one inhibitors of factor Xa is described. These compounds show nanomolar potency against FXa and maintain high selectivity over thrombin and trypsin.
ISSN:0960-894X
1464-3405
DOI:10.1016/S0960-894X(98)00386-2